Literature DB >> 11640972

Interactions between histaminergic and cholinergic systems in learning and memory.

L Bacciottini1, M B Passani, P F Mannaioni, P Blandina.   

Abstract

The aim of this review is to survey biochemical, electrophysiological and behavioral evidence of the interactions between the cholinergic and histaminergic systems and evaluate their possible involvement in cognitive processes. The cholinergic system has long been implicated in cognition, and there is a plethora of data showing that cholinergic deficits parallel cognitive impairments in animal models and those accompanying neurodegenerative diseases or normal aging in humans. Several other neurotransmitters, though, are clearly implicated in cognitive processes and interact with the cholinergic system. The neuromodulatory effect that histamine exerts on acetylcholine release is complex and multifarious. There is clear evidence indicating that histamine controls the release of central acetylcholine (ACh) locally in the cortex and amygdala, and activating cholinergic neurones in the nucleus basalis magnocellularis (NBM) and the medial septal area-diagonal band that project to the cortex and to the hippocampus, respectively. Extensive experimental evidence supports the involvement of histamine in learning and memory and the procognitive effects of H(3) receptor antagonists. However, any attempt to strictly correlate cholinergic/histaminergic interactions with behavioral outcomes without taking into account the contribution of other neurotransmitter systems is illegitimate. Our understanding of the role of histamine in learning and memory is still at its dawn, but progresses are being made to the point of suggesting potential treatment strategies that may produce beneficial effects on neurodegenerative disorders associated with impaired cholinergic function.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11640972     DOI: 10.1016/s0166-4328(01)00230-3

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  17 in total

1.  Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.

Authors:  Allison B Gold; Caryn Lerman
Journal:  Hum Genet       Date:  2012-01-31       Impact factor: 4.132

2.  Long-term effects of methamphetamine exposure on cognitive function and muscarinic acetylcholine receptor levels in mice.

Authors:  Jessica A Siegel; Michael J Craytor; Jacob Raber
Journal:  Behav Pharmacol       Date:  2010-10       Impact factor: 2.293

Review 3.  Classifying antipsychotic agents : need for new terminology.

Authors:  Ripu D Jindal; Matcheri S Keshavan
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

4.  H3 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing retrieval.

Authors:  Vincent Pascoli; Corinne Boer-Saccomani; Jean-François Hermant
Journal:  Psychopharmacology (Berl)       Date:  2008-05-22       Impact factor: 4.530

5.  Additive effects of a cholinesterase inhibitor and a histamine inverse agonist on scopolamine deficits in humans.

Authors:  William Cho; Paul Maruff; John Connell; Cindy Gargano; Nicole Calder; Scott Doran; Sabrina Fox-Bosetti; Aizza Hassan; John Renger; Gary Herman; Christopher Lines; Ajay Verma
Journal:  Psychopharmacology (Berl)       Date:  2011-06-07       Impact factor: 4.530

6.  Methamphetamine exposure during brain development alters the brain acetylcholine system in adolescent mice.

Authors:  Jessica A Siegel; Byung S Park; Jacob Raber
Journal:  J Neurochem       Date:  2011-09-01       Impact factor: 5.372

7.  Determination of allelic expression of SNP rs1880676 in choline acetyltransferase gene in HeLa cells.

Authors:  Zhongli Yang; Chen Lin; Shaolin Wang; Chamindi Seneviratne; Jundong Wang; Ming D Li
Journal:  Neurosci Lett       Date:  2013-09-26       Impact factor: 3.046

8.  Ciproxifan, a histamine H3-receptor antagonist/inverse agonist, potentiates neurochemical and behavioral effects of haloperidol in the rat.

Authors:  Catherine Pillot; Jordi Ortiz; Anne Héron; Sophie Ridray; Jean-Charles Schwartz; Jean-Michel Arrang
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

9.  The histamine N-methyltransferase T105I polymorphism affects active site structure and dynamics.

Authors:  Karen Rutherford; W W Parson; Valerie Daggett
Journal:  Biochemistry       Date:  2007-12-23       Impact factor: 3.162

10.  Neuroprotective effect of biatractylenolide against memory impairment in D-galactose-induced aging mice.

Authors:  Zhi-Hong Ji; Chao Liu; Hong Zhao; Xin-Yu Yu
Journal:  J Mol Neurosci       Date:  2014-08-31       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.